Angiogenic Switch in Earliest Stages of Human Colonic Tumorigenesis

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5153-5157

  Shpitz, Baruch ^a   Gochberg, Semion ^a,b   Neufeld, David ^a,b   Grankin, Mila ^a   Buklan, Genadi ^a,b   Klein, Ehud ^a,b   Bernheim, Joelle ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aberrant crypt foci; Angiogenesis; Colorectal carcinogenesis; Precursor

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANGIOGENESIS; ARTICLE; CANCER PREVENTION; COLON CARCINOGENESIS; COLON MUCOSA; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL;

ASPIRIN; COLONIC NEOPLASMS; HUMANS; INTESTINAL MUCOSA; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS;

EID: 0842321838     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Winawer SJ: Natural history of colorectal cancer. Am J Med 106: 3S-6S, 1999.
2. Pinsky PF: A multi-stage model of adenoma development. J Theor Biol 207: 129-143, 2000.
3. Ponz de Leon M and Di Gregorio C: Pathology of colorectal cancer. Dig Liver Dis 33: 372-388, 2001.
4. Pretlow TP, O'Riordan MN, Pretlow TG and Stellato TA: Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 16G: 55-62, 1992.
5. Dolara P, Caderini G and Luceri C: Surrogate endpoint biomarkers for human colon carcinogenesis. Toxicol Lett 112-113: 415-420, 2000.
6. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H and Niitsu Y: Aberrat crypt foci of the colons as precursors of adenoma and cancer. N Engl J Med 339: 1277-1284, 1998.
7. Bird RP and Good CK: The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters 112-113: 395-402, 2000.
8. Nascimbeni R, Villanacci V, Mariani PP, Di Betta E, Ghirardi M, Donato F and Salerini B: Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol 23: 1256-1263, 1999.
9. Augenlight LH, Richards C, Corner G and Pretlow TP: Evidence for genomic instability in human aberrant crypt foci. Oncogene 12: 1767-1772, 1996.
10. Shpitz B, Bornstein Y, Mekori Y, Cohen R, Kaufman Z, Neufeld D, Galkin M and Bernheim J: Aberrant crypt foci in human colons: distribution and histomorphological characteristics. Hum Pathol 29: 10-13, 1998.
11. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV and Gallinger S: Somatic APC and K-ras mutations in aberrant crypt foci from human colons. Cancer Res 54: 5527-5530, 1994.
12. Siu IM, Pretlow TG, Amini SB and Pretlow TP: Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 150: 1805-1813, 1997.
13. Papetti M and Herman IM: Mechnisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-970, 2002.
14. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
15. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29 Suppl: 15-18, 2002.
16. Takahashi Y, Bucana CD, Cleary KR and Ellis LM: P53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79: 34-38, 1998.
17. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR and Hellman S: Angiogenesis as a predictor of long term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88: 1764-1769, 1996.
18. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC, Harris AL and Gatter KC: Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179: 80-88, 1996.
19. Folkman J, Watson K, Inber D and Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.
20. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H and Sasse J: Increased levels of FGF-like activity in urine from patients with bladder or kidney cancer. Cancer Res 48: 2083-2088, 1988.
21. Smith-McCune KK and Weidner N: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54: 800-804, 1994.
22. Engels K, Fox SB, Whitehouse RM, Gatter KC and Harris AL: Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 181: 207-212, 1997.
23. Aotake T, Lu C-D, Chiba Y, Muraok R and Tanigava N: Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis. Clin Cancer Res 5: 149-154, 1999.
24. Shpitz B, Bornstein Y, Mekori Y, Cohen R, Kaufman Z, Gramkin M and Bernheim J: Proliferative cell kinetics in aberrant crypt foci, adenomas and adenocarcinomas of the large bowel. Am J Surg 174: 425-430, 1997.
25. Di Gregorio C, Losi L, Fante R, Modica S, Ghidoni M, Pedroni M, Tamassia MG, Gafa L, Ponz de Leon M and Roncucci L: Histology of ACF in human colons. Histopathology 30: 328-334, 1997.
26. Wargowich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K and Kelloff GJ: Efficacy of potential chemopreventive agents on rat colon aberrant crypt foci formation and progression. Carcinogenesis 21: 1149-55, 2000.
27. Konstantakos AK, Siu IM, Pretlow TG, Stellato TA and Pretlow TP: Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111: 772-777, 1996.
28. Nucci MR, Robinson CR, Longo P, Campbell P and Hamilton SR: Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28: 1396-1407, 1997.
29. Enimoto T, Kuranami M and Kakita A: Variation in expression of platelet-derived endothelial cell growth factor in human colorectal polyps. Surg Today 30: 711-717, 2000.
30. Takahashi Y, Ellis LM and Mai M: The angiogenic switch of human colon cancer occurs simultaneously to initiation of invasion. Oncol Rep 10: 9-13, 2003.
31. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendsten O, Werb Z, Caughley GH and Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes and Development 13: 1382-1397, 1999.
32. Kuniyashu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, Bucana CD, Rikita T, Tahara E and Fidler IJ: Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 157: 1523-1535, 2000.
33. Sandler RS, Galanko JC, Murray SC, Helm JF and Woosley JT: Aspirin and other non-steroidal anti-inflammatory agents and risk for colorectal cancer. Gastroenterology 114: 441-447, 1998
34. Shiff SJ and Rigas B: Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113: 1192-1998, 1997.
35. Williams CS, Smalley W and DuBois RN: Aspirin use and potential mechanism for colorectal cancer prevention. J Clin Invest 100: 1325-29, 1997.
36. Shpitz B, Klein E, Buklan G, Neufeld D, Nissan A, Freund HR, Grankin M and Bernheim J: Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer. Gut 2003. (In press).
37. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IH and Tarnawski AS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into the mechanisms and implications for cancer growth and ulcer healing. Nature Med 5: 1418-1423, 1999.
38. Dannenberg AJ and Zakim D: Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin in Oncol 26: 449-504, 1999.
39. Tsugii M, Kawano S, Tsugi S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
40. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenoma and adenocarcinoma. Gastroenterology 107: 1183-1188, 1994.
41. Maekawa M, Sugano K, Sano H, Miyzaki S, Ushiama M, Fujita S, Gotoda T, Yokota T, Ohkura H, Kakizoe T and Seliya T: Increased expression of cyclooxygenase-2 and -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps. Jap J Clin Oncol 28: 421-6, 1998.
42. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S and Talbot IC: Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187: 295-301, 1999.